Skip to content

Colm Harrington

4 papers in the library · 5 citations · publishing 2024-2026

Papers

Sort Most recent Most cited

Trip killers: Addressing a critical knowledge gap in psychedelic research.

Journal of psychopharmacology (Oxford, England) May 1, 2026 Brian O'Mahony, Colm Harrington, Andrew Harkin et al.

Psychedelic drugs are increasingly under investigation as potential therapeutic agents for mental health conditions and are being increasingly used recreationally. Psychedelic use may result in an episode of intense psychological distress, commonly referred to as a "bad trip." Bad trips represent a potentially volatile, erratic, and dangerous situation, which may, in extreme cases, require...

Psilocybin reporting in media (PRiMe) for the treatment of depression

Irish Journal of Psychological Medicine December 18, 2025 Gurjot Brar, T. R. Jun. Burke, Andrew Gribben et al.

Abstract Objectives: Interest in psilocybin as a treatment for depression has risen over the past decade, fuelled by promising clinical trials and a rapidly evolving regulatory landscape. Media coverage plays a critical role in shaping public perceptions, yet little is known about how psilocybin is portrayed in global anglophone online news for the treatment of depression. Methods: This study...

Amid magic and menace: psychiatrists’ attitudes to psilocybin therapy

Irish Journal of Psychological Medicine November 7, 2024 Andrew Gribben, Tara Burke, Colm Harrington et al. 5 citations

Abstract Objectives: Understanding variations in knowledge and attitudes of psychiatrists to psilocybin therapy is important for the collective discourse about the potential impact on clinical practice and public health in Ireland. Methods: A 28-item questionnaire was designed based on previous studies and distributed to psychiatrists in Ireland via online mailing lists and at in-person...

Amid magic and menace: psychiatrists' attitudes to psilocybin therapy.

2024 Jo-Hanna Ivers, Katy Tobin, Colm Harrington et al.

OBJECTIVES Understanding variations in knowledge and attitudes of psychiatrists to psilocybin therapy is important for the collective discourse about the potential impact on clinical practice and public health in Ireland. METHODS A 28-item questionnaire was designed based on previous studies and distributed to psychiatrists in Ireland via online mailing lists and at in-person academic events....